Archean Chemical Industries Limited — Q2 FY26
Archean Chemical's Q2 FY26 consolidated revenue declined 8% YoY to ₹239.6 crore, with EBITDA down 15% to ₹69 crore, reflecting a 28.8% margin.
neutral
medium
✓ Verified against BSE filing
Claim Ledger
Did management answer the analysts?
Every material analyst question, graded on whether management actually answered it — with the verbatim exchange and quantitative claims checked against filed numbers.
50%Questions answered3Evaded / deflected12Questions auditedContradictedNumbers vs filing
Partial answer
Medium priority
What is the one big change driving Archean's strength in global markets?
Asked by Sukrit Patel, Eyesight
Management listed multiple ongoing initiatives but did not identify a single transformative change.
no single big change identifiedlisted multiple ongoing initiatives
Read the exchange
Question
what is the one big thing or the one big change you're driving that will make Archean stronger and more trusted in the global markets?
Ranjit (Managing Director)
I think over the next couple of years we continue to focus on the core business... industrial salt, bromine and sulfate of potash business. We anticipate enough and more growth available in those three areas.
Partial answer
Medium priority
How does Archean protect margins without slowing growth?
Asked by Sukrit Patel, Eyesight
Management gave generic cost consciousness but no specific margin protection strategy.
no specific margin protection strategygeneric cost consciousness
Read the exchange
Question
I just want to understand how you think about protecting the profits without slowing down growth means like do you rely more on smarter sourcing or pricing control?
Ranjit (Managing Director)
we have to be able to navigate on a daily basis... what we can do is be very very conscious of cost... It's a combination of both good practices as well as continuously trying to see where we can reduce cost.
Answered
High priority
What are the sales volumes for industrial salt, bromine, and SOP?
Asked by Vin, Hathway Investments
Management provided exact volume numbers for each product.
Read the exchange
Question
if somebody can just give us the sales volumes in quarter the in industrial salt bromine and SOP
Management (unidentified)
in quarter two the sales of industrial salt is 88,893 metric ton bromine is 3,160 metric ton SOP 26 metric ton
Answered
High priority
When will SOP commercial production and sales start?
Asked by Vin, Hathway Investments
Management gave specific timeline for SOP sales.
Read the exchange
Question
when will you start seeing the commercial production and the sales coming in
Management (unidentified)
the trial production will start in Q4... we will start production of this post monsoon next year... So we'll see Q3 FY27 the sales of SOP getting into our books.
Declined
High priority
What are the expected margins for SOP?
Asked by Vin, Hathway Investments
Management declined to share margin details, citing confidentiality and deferring to Q4.
confidentialdeferred to future
Read the exchange
Question
So what kind of roughly margins are you looking at? Can you share that or is it confidential?
Management (unidentified)
Well, I think one it's confidential but more importantly I think we'll probably provide a better update once the pilot plant's up and running in Q4
Partial answer
High priority
What are expectations for Orin hydrocarbon in H2 and FY27?
Asked by Arch Jooshi, Noama Wealth
Management gave qualitative update but no specific revenue or volume numbers.
no specific numbers givenqualitative only
Read the exchange
Question
what are our expectations in the second half? are we deriving any revenues from there? have we seen any ramp up if you can throw some number
Ranjit (Managing Director)
on orin it has been disappointingly slow... for the rest of the year I would not really consider any meaningful contribution... FY27 we expect some of those products to definitely start selling
Evasive
High priority
How will the 2067 crore capex be deployed over FY26-28?
Asked by Arch Jooshi, Noama Wealth
Management provided no timeline or phasing for the capex, deferring to future updates.
no timeline givendeferred to future
Read the exchange
Question
how should we number it in the model how do we see this being deployed is it like a two three year thing can you give some broad timelines
Rajiv (unidentified role)
it's a bit early to commit to that spreadsheet you want to build... the work has started and very soon we hope we'll be able to give a notification to stakeholders on the commencement of construction.
Partial answer
High priority
Why are bromine volumes low and will FY26 target of 25% be met?
Asked by Kanan, SMFS
Management explained low volumes due to monsoon but did not confirm if FY26 target would be met.
no direct answer on target achievementblamed weather
Read the exchange
Question
why is the volumes low and our target are we on track to meet by this fiscal FY26 of 25% which we have stated earlier?
Management (unidentified)
primarily on our side it's been a production challenge... prolonged monsoon... we are fixing certain problems at the equipment level but the demand stays robust.
Answered
High priority
What are bromine derivatives volume and revenue for this quarter?
Asked by Kanan, SMFS
Management provided H1 volume and revenue for bromine derivatives.
Read the exchange
Question
onto the bromine derivatives can we share the volume figure and the revenue share in this quarter
Natan (unidentified role)
what we in H1 you know um we have done 3,135 metric and value of 42 43 cr
Partial answer
Medium priority
How big can SOP business become in terms of topline?
Asked by Kanan, SMFS
Management acknowledged potential but deferred specific guidance.
no specific numberdeferred to trial completion
Read the exchange
Question
how bigger business this can be whether it can be a 500 cr or 1,000 cr topline business
Management (unidentified)
this has got a potential to reach the kind of numbers which you mentioned but the clarity will emerge once our trials are completed
Evasive
Medium priority
What caused lower bromine efficiency beyond monsoon?
Asked by Sana, Chola Securities
Management attributed lower efficiency solely to weather, not addressing internal difficulties.
blamed weather onlyno internal difficulty disclosed
Read the exchange
Question
could you speak on why the efficiency was lower? what was the internal difficulty that was there beyond a prolonged and erratic monsoon
Kan (unidentified role)
there were some technical challenges primarily contributed by the heavy rainfall unseasonal rainfall which led to dilution of the brine bromine concentration and consequently lower efficiency
Partial answer
High priority
What is Archean's equity contribution and timeline for the 2067 cr semiconductor project?
Asked by Rohit Nagarat, 361 Capital
Management gave equity percentage but no timeline for funding, deferring to future agreement.
timeline not givendeferred to agreement signing
Read the exchange
Question
what would be our contribution given that there will be state and support in terms of subsidies and what could be the timelines in terms of funding our equity for the project
Rajiv (unidentified role)
it will certainly be around 60 to 65% of the overall capital the 266 cr and the funding pattern will be pari passu... we are currently in the process of signing the fiscal support agreement
Quantitative claims vs filed numbers
| Claim | Management said | Filing | Verdict |
|---|---|---|---|
| Industrial salt revenue 171.48 cr in Q2 | ₹171.48 cr | ₹233 cr | Understated vs filing |
| Bromine revenue 72 cr in Q2 | ₹72 cr | ₹233 cr | Understated vs filing |
| SOP revenue 14 lakhs in Q2 | ₹0.14 cr | ₹233 cr | Understated vs filing |
| Bromine derivatives H1 revenue 42-43 cr | ₹42.5 cr | ₹233 cr | Understated vs filing |
| Bromine derivatives Q1 revenue 23 cr | ₹23 cr | ₹233 cr | Understated vs filing |
| Bromine derivatives Q2 revenue 20 cr | ₹20 cr | ₹233 cr | Understated vs filing |
Filed figures sourced from Screener.in. Claims within a small tolerance of the filing are marked “matches filing”.